Literature DB >> 2382970

Using age of onset to distinguish between subforms of breast cancer.

E B Claus1, N J Risch, W D Thompson.   

Abstract

Information on family history and age of onset of breast cancer is examined in an attempt to distinguish between postulated early and late onset forms of breast cancer and to estimate the familial correlation between any subforms that may exist. Data are taken from the Cancer and Steroid Hormone Study, a multicentre, population-based, case-control study conducted by the Centers for Disease Control (CDC). The data set includes 4730 histologically confirmed breast cancer cases aged 20-54 and 4688 controls who were frequency-matched to cases by geographic region and five-year categories of age. Data regarding family history of breast cancer for mothers and sisters of cases and controls are used in this analysis. The methods of Smith (1976) are modified to obtain maximum likelihood estimates of heritability and familial correlation using 35, 40, 45, and 50 years of age as the dividing point between early and late onset. The heritabilities for both the early and late onset forms decrease and approach one another in size with increasing age cutpoint, although the heritability for the early group is always greater than that for the late group. Irrespective of cutpoint, the familial correlation between the two groups does not differ significantly from one, providing evidence for a single genetic form of breast cancer with familial cases increasingly represented among cases with earlier onset.

Entities:  

Mesh:

Year:  1990        PMID: 2382970     DOI: 10.1111/j.1469-1809.1990.tb00373.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  9 in total

1.  An additive genetic gamma frailty model for linkage analysis of diseases with variable age of onset using nuclear families.

Authors:  Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2002-12       Impact factor: 1.588

2.  Modeling the effects of genetic factors on late-onset diseases in cohort studies.

Authors:  Mark E Glickman; David R Gagnon
Journal:  Lifetime Data Anal       Date:  2002-09       Impact factor: 1.588

3.  Mixture cure model with an application to interval mapping of quantitative trait loci.

Authors:  Mengling Liu; Wenbin Lu; Yongzhao Shao
Journal:  Lifetime Data Anal       Date:  2006-10-25       Impact factor: 1.588

4.  Exploring the link between germline and somatic genetic alterations in breast carcinogenesis.

Authors:  Núria Bonifaci; Bohdan Górski; Bartlomiej Masojć; Dominika Wokołorczyk; Anna Jakubowska; Tadeusz Dębniak; Antoni Berenguer; Jordi Serra Musach; Joan Brunet; Joaquín Dopazo; Steven A Narod; Jan Lubiński; Conxi Lázaro; Cezary Cybulski; Miguel Angel Pujana
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

5.  Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic.

Authors:  R S Houlston; L Lemoine; E McCarter; S Harrington; K MacDermot; J Hinton; L Berger; J Slack
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

6.  How many more breast cancer predisposition genes are there?

Authors:  D F Easton
Journal:  Breast Cancer Res       Date:  1999-08-23       Impact factor: 6.466

7.  Multivariate logistic regression for familial aggregation in age at disease onset.

Authors:  Abigail G Matthews; Dianne M Finkelstein; Rebecca A Betensky
Journal:  Lifetime Data Anal       Date:  2007-04-05       Impact factor: 1.429

Review 8.  The genetics of breast and ovarian cancer.

Authors:  D Ford; D F Easton
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

9.  Study of breast cancer incidence in patients of lymphangioleiomyomatosis.

Authors:  Olivier Nuñez; Antonio Román; Simon R Johnson; Yoshikazu Inoue; Masaki Hirose; Álvaro Casanova; Gorka Ruiz de Garibay; Carmen Herranz; Gema Bueno-Moreno; Jacopo Boni; Francesca Mateo; Anna Petit; Fina Climent; Teresa Soler; August Vidal; José Vicente Sánchez-Mut; Manel Esteller; José Ignacio López; Nadia García; Anna Gumà; Raúl Ortega; María Jesús Plà; Miriam Campos; Emilio Ansótegui; María Molina-Molina; Claudia Valenzuela; Piedad Ussetti; Rosalía Laporta; Julio Ancochea; Antoni Xaubet; Marina Pollán; Miguel Angel Pujana
Journal:  Breast Cancer Res Treat       Date:  2016-03-07       Impact factor: 4.872

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.